2004
DOI: 10.1016/j.maturitas.2004.01.009
|View full text |Cite
|
Sign up to set email alerts
|

The effects of hormone therapy on pulmonary function tests in postmenopausal women

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
31
0

Year Published

2006
2006
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(34 citation statements)
references
References 29 publications
1
31
0
Order By: Relevance
“…However, the exact mechanisms involved in lower lung function in postmenopausal women of the present study cannot be elucidated from this type of study. According to the suggestions made by different investigators, 8,9 lower percentages of predicted values of FVC and FEV 1 , PEFR, and FEF 25-75 in postmenopausal women in comparison to premenopausal women during follicular and luteal phase are most likely due to decreased level of progesterone and estrogen as observed in this study. Reduced levels of estrogen and progesterone would cause decreased muscular strength, decreased relaxation of bronchial smooth muscle, and increased compression of thoracic spine and as a result there is reduced total lung capacity.…”
supporting
confidence: 65%
See 1 more Smart Citation
“…However, the exact mechanisms involved in lower lung function in postmenopausal women of the present study cannot be elucidated from this type of study. According to the suggestions made by different investigators, 8,9 lower percentages of predicted values of FVC and FEV 1 , PEFR, and FEF 25-75 in postmenopausal women in comparison to premenopausal women during follicular and luteal phase are most likely due to decreased level of progesterone and estrogen as observed in this study. Reduced levels of estrogen and progesterone would cause decreased muscular strength, decreased relaxation of bronchial smooth muscle, and increased compression of thoracic spine and as a result there is reduced total lung capacity.…”
supporting
confidence: 65%
“…In postmenopausal women, relationship between low level of estrogen and progesterone and the changes in FEF and PEFR has been explored by several investigators of different countries. [8][9][10] In this study, mean percentage of predicted values of FEF 25-75 and PEFR was lower in postmenopausal women. Various mechanisms have been proposed for these observed changes in lung function in postmenopausal women.…”
Section: Discussionmentioning
confidence: 81%
“…The standardized mortality rate is almost twice higher in women than men among individuals with COPD who participated in a survey in which the average age upon entry was 56.6 yr (27). Thus evidence is growing to indicate estrogen may delay the loss of, and improve, those lung functions that reflect maintenance of alveolar structure (3,4,13,25,30) and, as a consequence, the number of alveolar attachments to small conducting airways.…”
Section: Discussionmentioning
confidence: 99%
“…The most obvious factor would be oestrogen-related, and several studies have shown that post-menopausal women who use hormone replacement therapy (HRT) experience less pulmonary function decline and less inflammation than older women who do not take exogenous hormones. 31,[48][49][50] In the Cardiovascular Health Study, spirometry was performed on 2,353 women older than 65 years who could provide information on HRT use. FEV 1 was higher overall in women who were currently using HRT than in those who were not currently using HRT (1.82 L vs. 1.66 L, p<0.0001), including former smokers (currently using versus not currently using HRT: 1.76 L vs. 1.60 L, p=0.013) and never smokers (1.90 L vs. 1.72 L, p<0.0001).…”
Section: Susceptibilitymentioning
confidence: 99%